We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Feedback Plc | FDBK | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.50 | -2.50% | 19.50 | 11:29:50 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 20.00 | 19.50 | 20.00 | 19.50 | 20.00 |
| Industry Sector |
|---|
| ELECTRONIC & ELECTRICAL EQUIPMENT |
| Top Posts |
|---|
Posted at 03/12/2024 15:56 by ducatiman looks like we have an FDBK ramper, well that's a first.Wonder if he was sent by an institution? |
Posted at 03/12/2024 12:38 by ged5 Yes, but they seem to have some problems of their own. Perhaps FDBK will come good and change Amati Global Investors' minds about AIM. :) |
Posted at 02/12/2024 13:13 by ged5 I realise a number of us have become disillusioned with FDBK and are very sceptical about Oakley's pitch and what you've posted does seem to be correct.What I'm looking at is a substantial increase in holding by Cranston, increase by several directors both in the placing and in the market and small purchases by Oakley and Patel. Even Eschauzier has bought back the ones he sold by mistake. Seguro Nominees have reduced but Canaccord have made an initial purchase. Not sure if Charlton has increased or decreased and Hayball hasn't bought any that I can see. If those two have bought some I'd feel more confident about future success for FDBK. Even so it's made me wonder with these director buys and a long standing holder such as Cranston giving further backing whether there is likely to be a change of fortune come April. Let's see if I'm brave/foolish enough to purchase more when I have available funds. |
Posted at 02/12/2024 10:18 by yump You’ll have to second-guess when the vast number of 20p holders will bail then.Unless they say otherwise, the cash is going to be used very quickly, because they’re having to fund each system, with no monetary contract and then hope they get enough patients through to get the per-patient cash. They are also “selling” I may be fed up with FDBK, but those are the facts of the current situation. To be fair, they do have an MOU for a pilot. That must be worth at least erm, well, pick a figure in the billions because it could be a whole new operational model for the NHS, funded by FDBK shareholders. |
Posted at 28/11/2024 15:00 by ducatiman FDBK up 2.5% as it surpasses Ryanair for number of pilots and hints that its getting on well with the current Govt despite countrywide scepticism.Nobody believes them anymore. |
Posted at 05/11/2024 13:06 by yump I thought about 12 months worth of working capital, but given the way revenue from the collaboration is likely to flow, not enough.Saving grace might be if any sort of initial contract payment is likely to cover some costs before there’s a flow of patients that results in the per-patient payments. Never know - perhaps a likely or guaranteed number of patients can be pre-paid from the funding. I can’t believe that any business would enter into a committment without any guaranteed payment. FDBK isn’t a travelling salesman working purely on commission. |
Posted at 04/11/2024 13:24 by martinmc123 2*Feedback plc, the clinical infrastructure specialist, posted FY results for the 12 months to 31 May 2024 this morning and these were pretty poor. Headline revenue performance was strong with a 15% increase in revenue to £1.18m (2023: £1.02m) with Bleepa® contributing 87% of the total. But sales were down to £0.95m from 2023: £1.27m, a drop of around 25%. And the Group slid further into loss as well with EBITDA loss increasing to £2.73m from 2023: £2.61m... ...from WealthOracle wealthoracle.co.uk/d |
Posted at 04/11/2024 07:51 by yump But TO says “there’s no better time to invest in the company”.I guess that’s why the issue price is 20p. I think a few of us thought a placing would be coming because the new amazing collaboration only gets paid per patient. So FDBK have to install Bleepa/Carelocker at their expense and hope enough clinicians use it with patients to make it pay. All the financial risk is now with FDBK. Written off my investment. This will die a long slow death. |
Posted at 01/11/2024 16:07 by pugugly FDBK not in the top 20 holdings |
Posted at 16/10/2024 06:40 by yump Sort of good news - perhaps.So ring fenced and diverted capital budgets are supposedly an obstacle. Now there is a fund in revenue spend for diverting patients away from normal outpatient process. That doesn’t answer the question of how many trusts are interested but stuck with the capital spend problem. That is what I want to know. We have never been told that crucial information. It also doesn’t cover the overall process of implementing Bleepa in a location, because its per-patient funding. Can a trust get advance funding for a prospective number of patients, or does FDBK have to carry the implementaion spend/effort before any cash is forthcoming - and that depends on patient flow. So is there a contract committment from a trust ? Without it FDBK will be like a charity and so will shareholders. The fact that they need an implementation partner makes me think they have been useless in getting even committment in principle from more tham a handful of trusts. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
